On Monday, Colleen successfully defended her thesis titled “Developing Microfluidic Devices for the Optimization of Nanodiscs to Measure Membrane Protein Structure and Function."
In the coming weeks, Dr. Riordan will begin working at GlaxoSmithKline as an Investigator.
Congratulations and best wishes to Colleen from all of us in the Bailey Lab!!
